Activation of innate immune responses through Toll-like receptor 3 causes a rapid loss of salivary gland function

Journal of Oral Pathology and Medicine

Volumn 38, Issue 1, 2009, Pages 42-47

  Deshmukh, Umesh S ^a,b   Nandula, Seshagiri Rao ^a   Thimmalapura, Pushpa Rekha ^a   Scindia, Yogesh M ^a   Bagavant, Harini ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Inflammatory cytokines; Poly(I:C); Salivary gland; Sj gren's syndrome; Toll like receptor 3

Indexed keywords

INTERFERON; PILOCARPINE; POLYINOSINIC POLYCYTIDYLIC ACID; RNA; SODIUM CHLORIDE; TOLL LIKE RECEPTOR 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; MOUSE; NEW ZEALAND BLACK MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND DISEASE; SJOEGREN SYNDROME;

ANIMALS; CHEMOKINE CCL5; FEMALE; IMMUNITY, INNATE; IMMUNOHISTOCHEMISTRY; INTERFERON INDUCERS; INTERFERON TYPE I; INTERLEUKIN-1BETA; INTERLEUKIN-6; MICE; MICE, INBRED NZB; MUSCARINIC AGONISTS; PILOCARPINE; POLY I-C; POLYMERASE CHAIN REACTION; SALIVA; SALIVARY DUCTS; SECRETORY RATE; SUBMANDIBULAR GLAND; TOLL-LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 58149170722     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2008.00700.x     Document Type: Article

References (22)

1. Jonsson R, Bolstad AI, Brokstad KA, et al. Sjogren's syndrome - a plethora of clinical and immunological phenotypes with a complex genetic background. Ann N Y Acad Sci 2007 1108 : 433 47.
2. Dawson LJ, Caulfield VL, Stanbury JB, et al. Hydroxychloroquine therapy in patients with primary Sjogren's syndrome may improve salivary gland hypofunction by inhibition of glandular cholinesterase. Rheumatology (Oxford) 2005 44 : 449 55.
3. Dawson LJ, Fox PC, Smith PM. Sjogren's syndrome - the non-apoptotic model of glandular hypofunction. Rheumatology (Oxford) 2006 45 : 792 8.
4. Manoussakis MN, Kapsogeorgou EK. The role of epithelial cells in the pathogenesis of Sjogren's syndrome. Clin Rev Allergy Immunol 2007 32 : 225 30.
5. Vercammen E, Staal J, Beyaert R. Sensing of viral infection and activation of innate immunity by toll-like receptor 3. Clin Microbiol Rev 2008 21 : 13 25.
6. Ohyama Y, Carroll VA, Deshmukh U, et al. Severe focal sialadenitis and dacryoadenitis in NZM2328 mice induced by MCMV: a novel model for human Sjogren's syndrome. J Immunol 2006 177 : 7391 7.
7. Kawakami A, Nakashima K, Tamai M, et al. Toll-like receptor in salivary glands from patients with Sjogren's syndrome: functional analysis by human salivary gland cell line. J Rheumatol 2007 34 : 1019 26.
8. Spachidou MP, Bourazopoulou E, Maratheftis CI, et al. Expression of functional toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjögren's syndrome. Clin Exp Immunol 2007 147 : 497 503.
9. Ittah M, Miceli-Richard C, Gottenberg JE, et al. Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependent and -independent pathways. Eur J Immunol 2008 38 : 1 7.
10. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001 25 : 402 8.
11. Bagavant H, Sharp C, Kurth B, et al. Induction and immunohistology of autoimmune ovarian disease in cynomolgus macaques (Macaca fascicularis). Am J Pathol 2002 160 : 141 9.
12. Alexopoulou L, Holt AC, Medzhitov R, et al. Recognition of double-stranded RNA and activation of NF-kB by Toll-like receptor 3. Nature 2001 413 : 732 8.
13. Matsumoto M, Seya T. TLR3: Interferon induction by double-stranded RNA including poly (I:C). Adv Drug Deliv Rev 2008 60 : 805 12.
14. Kawai T, Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med 2007 13 : 460 9.
15. Hjelmervik TOR, Petersen K, Jonassen I et al. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects. Arthritis Rheum 2005 52 : 1534 44.
16. Gottenberg JE, Cagnard N, Lucchesi C, et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome. Proc Natl Acad Sci U S A 2006 103 : 2770 5.
17. De Santi L, Costantini MC, Annunziata P. Long time interval between multiple sclerosis onset and occurrence of primary Sjögren's syndrome in a woman treated with interferon-beta. Acta Neurol Scand 2005 112 : 194 6.
18. Zoukhri D, Macari E, Kublin CL. A single injection of interleukin-1 induces reversible aqueous-tear deficiency, lacrimal gland inflammation, and acinar and ductal cell proliferation. Exp Eye Res 2007 84 : 894 904.
19. Steinfeld S, Cogan E, King LS, et al. Abnormal distribution of aquaporin-5 water channel protein in salivary glands from Sjogren's syndrome patients. Lab Invest 2001 81 : 143 8.
20. Yao C, Li X, Murdiastuti K, et al. Lipopolysaccharide-induced elevation and secretion of interleukin-1beta in the submandibular gland of male mice. Immunology 2005 116 : 213 22.
21. Zoukhri D, Kublin CL. Impaired neurotransmitter release from lacrimal and salivary gland nerves of a murine model of Sjogren's syndrome. Invest Ophthalmol Vis Sci 2001 42 : 925 32.
22. Lomniczi A, Mohn C, Faletti A, et al. Inhibition of salivary secretion by lipopolysaccharide: possible role of prostaglandins. Am J Physiol Endocrinol Metab 2001 281 : 405 11.